e-learning
resources
Paris 2018
Monday, 17.09.2018
Lung cancer: novel prognostic markers and scores
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is neutrophil/lymphocyte ratio at the time of diagnosis a valuable prognostic factor in non-small cell lung cancer?
F. Bodur Yildirim (Ankara, Turkey), N. Sevimli (Ankara, Turkey), M. TüRk (Kayseri, Turkey), N. YiLmaz Demirci (Ankara, Turkey), A. Yurdakul (Ankara, Turkey), C. öZtüRk (Ankara, Turkey)
Source:
International Congress 2018 – Lung cancer: novel prognostic markers and scores
Session:
Lung cancer: novel prognostic markers and scores
Session type:
Thematic Poster
Number:
2785
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Bodur Yildirim (Ankara, Turkey), N. Sevimli (Ankara, Turkey), M. TüRk (Kayseri, Turkey), N. YiLmaz Demirci (Ankara, Turkey), A. Yurdakul (Ankara, Turkey), C. öZtüRk (Ankara, Turkey). Is neutrophil/lymphocyte ratio at the time of diagnosis a valuable prognostic factor in non-small cell lung cancer?. 2785
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Prognostic value of neutrophil to lymphocyte ratio in patients with advanced non-small cell lung cancer
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021
PD-L1 is a potential negative prognostic factor for non-small cell lung cancer: A 5-year-follow-up study
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Year: 2011
The prognostic value of the albumin-to-fibrinogen ratio in lung cancer patients.
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019
Is gender a prognostic factor in long term survival non-small cell lung cancer?
Source: Eur Respir J 2002; 20: Suppl. 38, 185s
Year: 2002
Apelin expression is a prognostic factor in non-small cell lung cancer
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
HER2/
Neu
overexpression as independent negative prognostic factor for non-small cell lung cancer
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
A meta-analysis assessing the prognostic value of neutrophil to lymphocyte ratio in lung metastasectomy for colorectal cancer
Source: Virtual Congress 2021 – Innovation in thoracic surgery
Year: 2021
FDG-PET SUVmax is an independent prognostic indicator in patients with non-small cell lung cancer
Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients
Year: 2011
Effects of prognostic factors on survival of the patients of non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 326s
Year: 2005
Time in lung cancer diagnosis and its prognostic implication
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018
Prognostic value of integrated FDG-PET/CT in non-small cell lung cancer
Source: Annual Congress 2008 - New imaging techniques in chest imaging
Year: 2008
Procalitonin: A prognosis factor in lung cancer and a marker for small-cell lung cancer
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011
Prognostic value of comorbidity in operated non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 763s
Year: 2006
COX-2 as prognostic factor in lung cancer: systematic review of the literature with meta-analysis
Source: Annual Congress 2005 - Prognostic factors in lung cancer
Year: 2005
Survival and prognostic factors of oligometastatic non-small cell lung carcinoma: A single center experience
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017
Assessing the relevance of biological prognostic indices in predicting survival in non-small cell lung cancer
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
Clinicopathological significance and prognostic importance of circulating plasma DNA expression in advanced non-small cell lung cancer and its efficacy as a diagnostic tool
Source: Annual Congress 2012 - New insights in the pathology of lung cancer
Year: 2012
Effects of pretreatment prognostic factors and treatment on survival in advanced nonsmall cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 431s
Year: 2003
Tumour metabolic-flow difference as a potential predictor of survival in non-small cell lung cancer (NSCLC)
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept